Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Advancing bioluminescence imaging technology for the evaluation of anticancer agents in the MDA-MB-435-HAL-Luc mammary fat pad and subrenal capsule tumor modelsCathy Zhang, Zhengming Yan, Maria E Arango, et al.
Frontiers in Immunology|February 28, 2022
A DNA-Methylation-Driven Genes Based Prognostic Signature Reveals Immune Microenvironment in Pancreatic CancerMingjia Xiao, Xiangjing Liang, Zhengming Yan, et al.
Stem Cells Translational Medicine|February 15, 2013
Synergistic effect of the γ-secretase inhibitor PF-03084014 and docetaxel in breast cancer modelsCathy C Zhang, Zhengming Yan, Qing Zong, et al.
Cancer & Metabolism|November 28, 2013
Monitoring metabolic responses to chemotherapy in single cells and tumors using nanostructure-initiator mass spectrometry (NIMS) imagingPeter J O'Brien, Michelle Lee, Mary E Spilker, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 22, 2024
HDAC inhibitors support long-term expansion of porcine hepatocytes in vitroGuanhong Li, Min Zeng, Zhengming Yan, et al.
Neoplasia (New York, N.Y.)|November 25, 2017
Gemtuzumab Ozogamicin (GO) Inclusion to Induction Chemotherapy Eliminates Leukemic Initiating Cells and Significantly Improves Survival in Mouse Models of Acute Myeloid LeukemiaCathy C Zhang, Zhengming Yan, Bernadette Pascual, et al.
Cancer Medicine|February 28, 2014
Comparison of dynamic contrast-enhanced MR, ultrasound and optical imaging modalities to evaluate the antiangiogenic effect of PF-03084014 and sunitinibCathy C Zhang, Zhengming Yan, Anand Giddabasappa, et al.
Frontiers in Pharmacology|November 15, 2021
Therapeutic Potential of CUDC-907 (Fimepinostat) for Hepatocarcinoma Treatment Revealed by Tumor Spheroids-Based Drug ScreeningWei Liao, Wanren Yang, Jiecheng Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2009
PF-00477736 mediates checkpoint kinase 1 signaling pathway and potentiates docetaxel-induced efficacy in xenograftsCathy Zhang, Zhengming Yan, Cory L Painter, et al.
Molecular Cancer Therapeutics|April 17, 2008
Pharmacologic properties of AG-012986, a pan-cyclin-dependent kinase inhibitor with antitumor efficacyCathy Zhang, Karen Lundgren, Zhengming Yan, et al.
Pageof 2